NCT00801892

Brief Summary

Daily physical activity is important to achieve glucose control in persons with type 2 diabetes. The purpose of this study is to explore if obstructive sleep apnea and its daytime symptom, excessive sleepiness, act as barriers to physical activity. We will examine if treatment of obstructive sleep apnea with continuous positive airway pressure results in increased physical activity in persons with type 2 diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Apr 2009

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 4, 2008

Completed
4 months until next milestone

Study Start

First participant enrolled

April 1, 2009

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
2 years until next milestone

Results Posted

Study results publicly available

March 27, 2014

Completed
Last Updated

November 8, 2017

Status Verified

November 1, 2017

Enrollment Period

3 years

First QC Date

December 3, 2008

Results QC Date

February 11, 2014

Last Update Submit

November 6, 2017

Conditions

Keywords

daytime sleepinessobstructive sleep apneatype 2 diabetes mellitusdiabetes management

Outcome Measures

Primary Outcomes (1)

  • Physical Activity, Steps Walked

    Steps walked measured by the Bodymedia SenseWear Pro Armband®Data collected from the main study period

    after one-month treatment

Secondary Outcomes (5)

  • Fructosamine

    after one-month

  • Change in Sleep Quality

    after one month

  • Change in Daytime Sleepiness During Main Study Period

    after one month

  • Change in Vigor-Activity During Main Study Period

    after one month

  • Fatigue/Inertia

    after one month

Study Arms (2)

1 subjects treated with CPAP

ACTIVE COMPARATOR

Continuous Positive Airway Pressure treatment (CPAP)

Device: Continuous Positive Airway Pressure (CPAP)

2 subjects treated with sham-CPAP

SHAM COMPARATOR

Sham Continuous Positive Airway Pressure treatment (sham-CPAP)

Device: Sham- Continuous Positive Airway Pressure (Sham-CPAP)

Interventions

Mask worn over nose to splint open the airway with positive pressure to prevent the subject from holding their breath (apneas).

1 subjects treated with CPAP

Mask worn over nose to splint open the airway with positive pressure to prevent the subject from holding their breath (apneas).

2 subjects treated with sham-CPAP

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • T2DM (verified by primary care provider (PCP) or medication for T2DM)
  • AHI (from PSG) greater than \> 15
  • A1c \< 9.0%
  • Epworth Sleepiness Sca;e \> 10 (Baseline Assessment)
  • Able to ambulate independently or with a cane
  • Age 40-65 years
  • BMI\< 45
  • No acute medical and psychiatric illness in past 3 months
  • Self-reported sleep duration of at least 6 hours
  • No changes in medications, including diabetic medications, in last 3 months
  • Telephone access
  • Able to perform study tests (e.g., speak, read and write in English)
  • Willing to be randomized to CPAP or sham-CPAP

You may not qualify if:

  • Diagnosis of another sleep disorder, in addition to OSA,
  • Oxygen or Bi-level positive airway pressure required for treatment of OSA
  • An oxygen saturation \<75% for \>10% of the diagnostic PSG or if subject has oxygen saturation \<75% for \>25% of the first 4 h of the diagnostic PSG
  • Any individual in the household currently or with history of CPAP treatment
  • Type 1 or gestational diabetes
  • Prescribed insulin for treatment of type 2 diabetes
  • Regular use (\> 3 times/week) of hypnotic or alerting medications
  • History of a near-miss or automobile accident due to sleepiness
  • Employed in transportation-related safety sensitive occupation such as an airline pilot, truck driver, or train engineer
  • Currently working night or rotating shifts
  • Routine consumption of alcohol as determined by \>2 drinks day
  • Known allergy to medical adhesives or dermatological conditions that would preclude wearing CGMS
  • Swim or water aerobics \>once a week
  • Participation in contact sports or activity that may damage CGMS device or cause injury from monitor
  • Claustrophobia that prevents wearing the CPAP mask
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15261, United States

Location

MeSH Terms

Conditions

Sleep Apnea, ObstructiveDiabetes Mellitus, Type 2Disorders of Excessive Somnolence

Interventions

Continuous Positive Airway Pressure

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Results Point of Contact

Title
E. Chasens, PhD
Organization
University of Pittsburgh

Study Officials

  • Eileen R. Chasens, DSN

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The mask and equipment appeared similar to actual CPAP but does not give pressure required to prevent OSA. Only CPAP naive persons eligible.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Model Details: Participants on sham-CPAP were allowed to try actual CPAP.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 3, 2008

First Posted

December 4, 2008

Study Start

April 1, 2009

Primary Completion

April 1, 2012

Study Completion

April 1, 2012

Last Updated

November 8, 2017

Results First Posted

March 27, 2014

Record last verified: 2017-11

Locations